Modalert 200, a cognitive enhancer, operates on neurotransmitters in the brain, particularly dopamine and norepinephrine. While primarily designed to enhance wakefulness and focus, its impact on these neurotransmitters has sparked interest in its potential influence on mood regulation. Understanding these mechanisms sets the stage for exploring its connection to depression.